Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary triglycerides, starches, and proteins are the three primary macronutrients that serve as the fundamental energy sources and structural components for the human body (Source: StatPearls, Physiology, Digestion and Absorption). Triglycerides are the predominant form of dietary fat, starches are complex carbohydrates composed of glucose units, and proteins are polymers of amino acids essential for tissue repair and enzymatic function (Source: NIH, Macronutrients). While these substances are not therapeutic targets in the traditional sense, such as a receptor or enzyme, their digestive and absorptive pathways are critical focal points for treating metabolic and gastrointestinal diseases. Pharmacological agents often target the enzymes responsible for the breakdown of these macronutrients to modulate their uptake. For example, lipase inhibitors like orlistat prevent the hydrolysis of triglycerides, while alpha-glucosidase inhibitors like acarbose delay the digestion of starches into simple sugars (Source: PubChem, Orlistat; StatPearls, Acarbose). These interventions are primarily used to manage conditions like obesity and type 2 diabetes by reducing caloric absorption or postprandial glucose spikes. In cases of exocrine pancreatic insufficiency, exogenous versions of the enzymes that process these nutrients are administered as replacement therapy (Source: Mayo Clinic, Pancreatic Enzyme Replacement Therapy). Understanding the interaction between these dietary components and the digestive system is essential for developing strategies to combat metabolic syndrome and nutritional deficiencies.
Pharmacological intervention typically involves the inhibition of digestive enzymes (such as pancreatic lipase or alpha-glucosidase) to prevent the breakdown and subsequent absorption of these macronutrients, or the administration of exogenous enzymes to facilitate their digestion in cases of insufficiency.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary macronutrients (Triglycerides, Starches, and Proteins).